1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Oculoplastic Surgery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Oculoplastic Surgery Market, by Procedure Type
8.1.1. Eyelid Surgery (Blepharoplasty)
8.1.1.1. Market Revenue and Forecast
8.1.2. Orbital Surgery
8.1.2.1. Market Revenue and Forecast
8.1.3. Lacrimal Surgery (Tear Duct Procedures)
8.1.3.1. Market Revenue and Forecast
8.1.4. Facial Rejuvenation (Injectables, Fillers, Botox)
8.1.4.1. Market Revenue and Forecast
8.1.5. Reconstructive Oculoplastic Surgery
8.1.5.1. Market Revenue and Forecast
9.1. Oculoplastic Surgery Market, by Indication
9.1.1. Cosmetic/Aesthetic Indications
9.1.1.1. Market Revenue and Forecast
9.1.2. Functional Indications (Ptosis, Entropion, Ectropion)
9.1.2.1. Market Revenue and Forecast
9.1.3. Trauma & Reconstruction
9.1.3.1. Market Revenue and Forecast
9.1.4. Tumor Removal (Ocular Oncology-related)
9.1.4.1. Market Revenue and Forecast
10.1. Oculoplastic Surgery Market, by Product Type
10.1.1. Surgical Instruments (Forceps, Scissors, Retractors)
10.1.1.1. Market Revenue and Forecast
10.1.2. Implants & Stents (Orbital Implants, Lacrimal Stents)
10.1.2.1. Market Revenue and Forecast
10.1.3. Injectables (Botulinum Toxin, Dermal Fillers)
10.1.3.1. Market Revenue and Forecast
10.1.4. Laser & Energy-based Devices
10.1.4.1. Market Revenue and Forecast
11.1. Oculoplastic Surgery Market, by End-Use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Specialty Eye Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Ambulatory Surgical Centers (ASCs)
11.1.3.1. Market Revenue and Forecast
11.1.4. Analog, MEMS and Others
11.1.4.1. Market Revenue and Forecast
12.1. Oculoplastic Surgery Market, by Patient Type
12.1.1. Adult
12.1.1.1. Market Revenue and Forecast
12.1.2. Geriatric
12.1.2.1. Market Revenue and Forecast
12.1.3. Pediatric
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Procedure Type
13.1.2. Market Revenue and Forecast, by Indication
13.1.3. Market Revenue and Forecast, by Product Type
13.1.4. Market Revenue and Forecast, by End-Use
13.1.5. Market Revenue and Forecast, by Patient Type
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Procedure Type
13.1.6.2. Market Revenue and Forecast, by Indication
13.1.6.3. Market Revenue and Forecast, by Product Type
13.1.6.4. Market Revenue and Forecast, by End-Use
13.1.6.5. Market Revenue and Forecast, by Patient Type
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Procedure Type
13.1.7.2. Market Revenue and Forecast, by Indication
13.1.7.3. Market Revenue and Forecast, by Product Type
13.1.7.4. Market Revenue and Forecast, by End-Use
13.1.7.5. Market Revenue and Forecast, by Patient Type
13.2. Europe
13.2.1. Market Revenue and Forecast, by Procedure Type
13.2.2. Market Revenue and Forecast, by Indication
13.2.3. Market Revenue and Forecast, by Product Type
13.2.4. Market Revenue and Forecast, by End-Use
13.2.5. Market Revenue and Forecast, by Patient Type
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Procedure Type
13.2.6.2. Market Revenue and Forecast, by Indication
13.2.6.3. Market Revenue and Forecast, by Product Type
13.2.7. Market Revenue and Forecast, by End-Use
13.2.8. Market Revenue and Forecast, by Patient Type
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Procedure Type
13.2.9.2. Market Revenue and Forecast, by Indication
13.2.9.3. Market Revenue and Forecast, by Product Type
13.2.10. Market Revenue and Forecast, by End-Use
13.2.11. Market Revenue and Forecast, by Patient Type
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Procedure Type
13.2.12.2. Market Revenue and Forecast, by Indication
13.2.12.3. Market Revenue and Forecast, by Product Type
13.2.12.4. Market Revenue and Forecast, by End-Use
13.2.13. Market Revenue and Forecast, by Patient Type
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Procedure Type
13.2.14.2. Market Revenue and Forecast, by Indication
13.2.14.3. Market Revenue and Forecast, by Product Type
13.2.14.4. Market Revenue and Forecast, by End-Use
13.2.15. Market Revenue and Forecast, by Patient Type
13.3. APAC
13.3.1. Market Revenue and Forecast, by Procedure Type
13.3.2. Market Revenue and Forecast, by Indication
13.3.3. Market Revenue and Forecast, by Product Type
13.3.4. Market Revenue and Forecast, by End-Use
13.3.5. Market Revenue and Forecast, by Patient Type
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Procedure Type
13.3.6.2. Market Revenue and Forecast, by Indication
13.3.6.3. Market Revenue and Forecast, by Product Type
13.3.6.4. Market Revenue and Forecast, by End-Use
13.3.7. Market Revenue and Forecast, by Patient Type
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Procedure Type
13.3.8.2. Market Revenue and Forecast, by Indication
13.3.8.3. Market Revenue and Forecast, by Product Type
13.3.8.4. Market Revenue and Forecast, by End-Use
13.3.9. Market Revenue and Forecast, by Patient Type
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Procedure Type
13.3.10.2. Market Revenue and Forecast, by Indication
13.3.10.3. Market Revenue and Forecast, by Product Type
13.3.10.4. Market Revenue and Forecast, by End-Use
13.3.10.5. Market Revenue and Forecast, by Patient Type
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Procedure Type
13.3.11.2. Market Revenue and Forecast, by Indication
13.3.11.3. Market Revenue and Forecast, by Product Type
13.3.11.4. Market Revenue and Forecast, by End-Use
13.3.11.5. Market Revenue and Forecast, by Patient Type
13.4. MEA
13.4.1. Market Revenue and Forecast, by Procedure Type
13.4.2. Market Revenue and Forecast, by Indication
13.4.3. Market Revenue and Forecast, by Product Type
13.4.4. Market Revenue and Forecast, by End-Use
13.4.5. Market Revenue and Forecast, by Patient Type
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Procedure Type
13.4.6.2. Market Revenue and Forecast, by Indication
13.4.6.3. Market Revenue and Forecast, by Product Type
13.4.6.4. Market Revenue and Forecast, by End-Use
13.4.7. Market Revenue and Forecast, by Patient Type
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Procedure Type
13.4.8.2. Market Revenue and Forecast, by Indication
13.4.8.3. Market Revenue and Forecast, by Product Type
13.4.8.4. Market Revenue and Forecast, by End-Use
13.4.9. Market Revenue and Forecast, by Patient Type
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Procedure Type
13.4.10.2. Market Revenue and Forecast, by Indication
13.4.10.3. Market Revenue and Forecast, by Product Type
13.4.10.4. Market Revenue and Forecast, by End-Use
13.4.10.5. Market Revenue and Forecast, by Patient Type
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Procedure Type
13.4.11.2. Market Revenue and Forecast, by Indication
13.4.11.3. Market Revenue and Forecast, by Product Type
13.4.11.4. Market Revenue and Forecast, by End-Use
13.4.11.5. Market Revenue and Forecast, by Patient Type
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Procedure Type
13.5.2. Market Revenue and Forecast, by Indication
13.5.3. Market Revenue and Forecast, by Product Type
13.5.4. Market Revenue and Forecast, by End-Use
13.5.5. Market Revenue and Forecast, by Patient Type
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Procedure Type
13.5.6.2. Market Revenue and Forecast, by Indication
13.5.6.3. Market Revenue and Forecast, by Product Type
13.5.6.4. Market Revenue and Forecast, by End-Use
13.5.7. Market Revenue and Forecast, by Patient Type
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Procedure Type
13.5.8.2. Market Revenue and Forecast, by Indication
13.5.8.3. Market Revenue and Forecast, by Product Type
13.5.8.4. Market Revenue and Forecast, by End-Use
13.5.8.5. Market Revenue and Forecast, by Patient Type
14.1. AbbVie Inc. (Allergan Aesthetics)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Johnson & Johnson Vision
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Alcon Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bausch + Lomb Corporation
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Santen Pharmaceutical Co., Ltd.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Carl Zeiss Meditec AG
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Topcon Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Lumenis Ltd.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Ellex Medical Lasers Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Iridex Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
